Home Products Syrup

Neo-pulmolar

Composition:
Each 100 ml contains:
Dextromethorphan hydrobromide    125 mg
Chlorpheniramine maleate                20 mg

Properties:
Neo-pulmolar syrup contains Dextromethorphan hydrobromide which is an anti-tussive agent that acts centrally and elevates the threshold for coughing.
In therapeutic dosage, dextromethorphan does not inhibit ciliary activity.
It also contains Chlorpheniramine maleate which is an antihistamine, with anticholinergic (drying) and sedative side effects.
Chlorpheniramine maleate competitively antagonizes most of the smooth muscle stimulating actions of histamine on the H1 receptors of the bronchial muscle.
It also antagonizes the action of histamine that results in increased permeability and the formation of edema.

Indications & Usage:
Neo-pulmolar is used as anti-tussive and antihistamine.

Contraindications:
Neo-pulmolar syrup is contraindicated in:
- Patients receiving monoamine oxidase inhibitors.
- Patients who have hypersensitivity to any of the ingredients of the product.

Side effects:

Some of the following side effects may occur in some cases:
Dizziness, blurred vision, dry mouth, epigastric distress.

Drug interactions:
- Neo-pulmolar should not be used in patients receiving MAOIs and for 14 days after stopping the MAOI therapy.
- Additive CNS depression may occur when Neo-pulmolar is administered concomitantly with other CNS depressants including barbiturates, tranquilizers and alcohol.
- The action of oral anticoagulants may be diminished by Neo-pulmolar.

Warnings & Precautions:
- Neo-pulmolar syrup should be used with caution in sedated or debilitated patients, and in patients confined to the supine position.
- Neo-pulmolar syrup should be used with caution in patients with a history of bronchial asthma, increased intraocular pressure, hyperthyroidism, cardiovascular disease and hypertension.
- Neo-pulmolar syrup may diminish mental alertness in children, in the young child particularly, it may produce excitation.

Pregnancy:
Neo-pulmolar syrup should be used in pregnancy only if clearly needed.

Lactation:
A decision should be made whether to discontinue nursing or to discontinue the drug taking into account the importance of the drug to the mother.

Overdosage:
Signs and symptoms of overdosage may vary from central nervous system depression to stimulation, also dizziness, ataxia and hypotension may occur. Very high doses may produce respiratory depression.

Treatment:
- Emergency treatment should be started immediately and vomiting should be induced by ipecae syrup.

Dosage and administration:
Adults: 2 dessertspoonful every 4-6 hours.
Children: 1-2 years: 1 teaspoonful twice daily.
                2-5 years: 1 teaspoonful every 4-6 hours.
                6-12 years: 2 teaspoonful every 4-6 hours.

Therapeutic category: Anti-tussive, Antihistamine.

Legal category: OTC.

Package: Bottles of 120 ml.

Storage: Protect from light, at a temperature below 30º C.

THIS IS A MEDICAMENT
Medicament is a product, which affects your health and its consumption contrary to instructions is dangerous for you. Follow strictly the doctor’s prescription, the method of use and the instructions of the pharmacist who sold the medicament.
- The doctor and the pharmacist are the experts in medicines, their benefits and risks.
- Do not by yourself interrupt the period of treatment prescribed.
- Do not repeat the same prescription without consulting your doctor.
- Keep all medicaments out of reach of children.

Council of Arab Health Ministers, Union of Arab Pharmacists.